Foster Dykema Cabot & Co. Inc. MA Purchases Shares of 340 Waters Co. (NYSE:WAT)
Foster Dykema Cabot & Co. Inc. MA Purchases Shares of 340 Waters Co. (NYSE:WAT)
Foster Dykema Cabot & Co. Inc. MA purchased a new stake in Waters Co. (NYSE:WAT – Get Rating) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 340 shares of the medical instruments supplier's stock, valued at approximately $113,000.
根據Waters Co.最近提交給美國證券交易委員會的13F文件，福斯特·Dykema Cabot&Co.Inc.Ma在第二季度購買了Waters Co.(紐約證券交易所代碼：WAT-GET Rating)的新股份。該機構投資者購買了這家醫療器械供應商的340股股票，價值約11.3萬美元。
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Ellevest Inc. boosted its stake in shares of Waters by 144.4% in the 1st quarter. Ellevest Inc. now owns 88 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 52 shares during the last quarter. Kenfarb & CO. bought a new stake in shares of Waters in the 4th quarter valued at $48,000. Tyler Stone Wealth Management bought a new stake in shares of Waters in the 4th quarter valued at $56,000. Allworth Financial LP boosted its stake in shares of Waters by 48.4% in the 2nd quarter. Allworth Financial LP now owns 187 shares of the medical instruments supplier's stock valued at $62,000 after purchasing an additional 61 shares during the last quarter. Finally, Quent Capital LLC bought a new stake in shares of Waters in the 4th quarter valued at $75,000. 88.80% of the stock is currently owned by institutional investors and hedge funds.
其他幾家機構投資者和對衝基金最近也增持或減持了該業務的股份。Ellevest Inc.在第一季度增持了144.4%的Waters股票。Ellevest Inc.現在持有這家醫療器械供應商88股股票，價值2.7萬美元，該公司在上個季度又購買了52股。肯法布公司在第四季度購買了Waters的新股份，價值4.8萬美元。泰勒·斯通財富管理公司(Tyler Stone Wealth Management)在第四季度購買了Waters價值5.6萬美元的新股。Allworth Financial LP在第二季度增持了48.4%的Waters股票。Allworth Financial LP在上個季度額外購買了61股後，現在擁有187股這家醫療器械供應商的股票，價值6.2萬美元。最後，Quent Capital LLC在第四季度購買了Waters的新股份，價值7.5萬美元。88.80%的股票目前由機構投資者和對衝基金持有。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
A number of equities research analysts have recently commented on WAT shares. Barclays reduced their price objective on shares of Waters from $375.00 to $345.00 and set an "overweight" rating on the stock in a research note on Monday, September 12th. Cowen increased their target price on shares of Waters to $378.00 in a research note on Tuesday, August 9th. Credit Suisse Group initiated coverage on shares of Waters in a research note on Wednesday, August 24th. They set a "neutral" rating and a $345.00 target price on the stock. Robert W. Baird increased their target price on shares of Waters from $340.00 to $348.00 in a research note on Wednesday, August 3rd. Finally, UBS Group increased their target price on shares of Waters from $349.00 to $375.00 and gave the stock a "neutral" rating in a research note on Thursday, August 4th. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $348.25.
一些股票研究分析師最近對Wat股票發表了評論。巴克萊將Waters股票的目標價從375.00美元下調至345.00美元，並在9月12日星期一的一份研究報告中對該股設定了“增持”評級。考恩在8月9日週二的一份研究報告中將Waters的目標價上調至378.00美元。瑞士信貸集團在8月24日星期三的一份研究報告中啟動了對Waters股票的報道。他們為該股設定了“中性”評級和345.00美元的目標價。羅伯特·W·貝爾德在8月3日星期三的一份研究報告中將Waters的目標股價從340.00美元上調至348.00美元。最後，瑞銀集團將Waters股票的目標價從349.00美元上調至375.00美元，並在8月4日(星期四)的一份研究報告中給出了該股“中性”的評級。五名投資分析師對該股的評級為持有，兩名分析師對該股的評級為買入。根據MarketBeat.com的數據，該股目前的共識評級為持有，共識目標價為348.25美元。
Waters Stock Up 0.1 %
Waters股價上漲0.1%
Waters (NYSE:WAT – Get Rating) last released its quarterly earnings data on Tuesday, August 2nd. The medical instruments supplier reported $2.75 earnings per share for the quarter, beating analysts' consensus estimates of $2.63 by $0.12. Waters had a net margin of 24.21% and a return on equity of 203.31%. The firm had revenue of $714.30 million for the quarter, compared to analyst estimates of $706.77 million. During the same period last year, the firm earned $2.60 earnings per share. The business's quarterly revenue was up 4.8% compared to the same quarter last year. On average, research analysts forecast that Waters Co. will post 12 earnings per share for the current year.
Waters(NYSE：WAT-GET評級)最近一次發佈季度收益數據是在8月2日星期二。這家醫療器械供應商公佈本季度每股收益為2.75美元，比分析師普遍預期的2.63美元高出0.12美元。Waters的淨利潤率為24.21%，股本回報率為203.31%。該公司本季度營收為7.143億美元，而分析師預期為7.0677億美元。去年同期，該公司每股收益為2.60美元。與去年同期相比，該業務的季度收入增長了4.8%。研究分析師平均預測，Waters Co.本年度每股收益將達到12歐元。
About Waters
關於沃特斯
(Get Rating)
(獲取評級)
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Waters Corporation是一家專業測量公司，在亞洲、美洲和歐洲提供分析工作流程解決方案。它通過兩個部門運營，Waters和TA。該公司設計、製造、銷售和服務高性能和超高性能液相色譜，以及質譜儀(MS)技術系統和支持產品，包括色譜柱、其他消耗品和保修後服務計劃。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Waters (WAT)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 免費獲取StockNews.com關於Waters的研究報告(Wat)
- 華爾街對Datadog的熱情會帶來巨大的收益嗎？
- MarketBeat：回顧一週9/19-9/23
- 為什麼特斯拉的股票保持彈性？
- 好市多盈利後價格疲軟是買入的好時機嗎？
- 小盤股的裁員是樓市的晴雨表嗎？
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Waters Daily》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Waters和相關公司的最新新聞和分析師評級的每日簡要摘要。